Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer

JH Ha, R Radhakrishnan, R Nadhan… - Cancer Letters, 2024 - Elsevier
Ovarian cancer ranks as a leading cause of mortality among gynecological malignancies,
primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear …

Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer

JH Ha, R Radhakrishnan, R Nadhan… - Cancer …, 2024 - research.uniupo.it
Ovarian cancer ranks as a leading cause of mortality among gynecological malignancies,
primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear …

Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer.

JH Ha, R Radhakrishnan, R Nadhan… - Cancer Letters, 2024 - europepmc.org
Ovarian cancer ranks as a leading cause of mortality among gynecological malignancies,
primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear …

Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer

H Ji Hee, R Radhakrishnan, R Nadhan… - CANCER …, 2024 - iris.uniupo.it
Ovarian cancer ranks as a leading cause of mortality among gynecological malignancies,
primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear …

Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer

JH Ha, R Radhakrishnan, R Nadhan… - Cancer …, 2024 - pubmed.ncbi.nlm.nih.gov
Ovarian cancer ranks as a leading cause of mortality among gynecological malignancies,
primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear …

Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer

JH Ha, R Radhakrishnan, R Nadhan… - Cancer …, 2024 - research.uniupo.it
Ovarian cancer ranks as a leading cause of mortality among gynecological malignancies,
primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear …